20 Oct 2017 | 7:30 PM
 

Glenmark Pharmaceuticals Ltd. Share Price Live (BSE)
0

BSE Code: 532296 | NSE Symbol: GLENMARK
606.25
-4.65
(-0.76 %)
18 Oct 2017 | 03:48 PM
Change company
  • Open (Rs)
    615.00
  • Prev. close (Rs.)
    610.90
  • High (Rs.)
    615.00
  • Low (Rs.)
    607.05
  • 52W H (Rs.)
    993.00
  • 52W L (Rs.)
    567.96
  • Volume
    28296
  • MCap (Rs in Cr.)
    17,106.44
607.5
-0.85
(-0.14 %)
  • Open (Rs)
    607.45
  • High (Rs)
    610.40
  • Low (Rs)
    607.00
  • Prev. close(Rs)
    608.35
  • Contracts Tra.
    2,43,600
  • Turnover (Cr.)
    15
  • Open Interest
    67,96,300
  • Open Int. chg
    67,83,700.00
1D| 1W| 1M | 3M | 6M | 1YR | MAX

Financials

EPS
39.30
Operating Margin (%)
22.17
Gross Profit Margin (%)
19.29
Net Profit Margin (%)
12.07
Total Debt/Equity
1.05
Dividend payout Ratio (Net Profit)
0.00
Earning Retention Ratio
100.00

News

16 Oct 2017 - 11:01:00-Glenmark Pharmaceuticals has said that it has been granted final approval by the United States Food ...
27 Sep 2017 - 12:04:00-Glenmark Pharmaceuticals has said that it has been granted final approval by the United States Food ...
20 Sep 2017 - 10:20:00-Leading pharma major Glenmark Pharmaceuticals has said that it has been granted final approval by th...
19 Sep 2017 - 10:25:00-Glenmark Pharmaceuticals has said that it has been granted final approval by the United States Food ...

Announcements

16-Oct-2017
Glenmark Pharma - Press Release
16-Oct-2017
Glenmark Pharma - Press Release / Media Release
12-Oct-2017
Glenmark Pharma - Certificate From Practicing Company Secretary Under Regulation 40(9) Of The SEBI (Listing Obligations And D
12-Oct-2017
Glenmark Pharma - Compliance Certificate Under Regulation 7(3) Of The SEBI (Listing Obligations And Disclosure Requirements)
12-Oct-2017
Glenmark Pharma - Shareholding for the Period Ended September 30 2017

Religare Research

18 Oct 2017 | 06:00 PM
This week, we haven’t initiated fresh position and advise taking position in running recommendation....
18 Oct 2017 | 06:00 PM
Nifty managed to inch higher amid volatility, tracking favorable local cues and supportive global ...
18 Oct 2017 | 09:58 AM
The Indian rupee fell for a first time in seven sessions against the dollar, as reports U.S. Preside...
18 Oct 2017 | 09:28 AM
Gold fell on hawkish views about possible next Fed chair  Oil prices turned lower after 2-session c...

Fund Interest

Schemes Shares Held Mkt. Value Latest Nav % Nav
10,00,000 115.06 79.42 -0.06
10,00,000 115.06 68.42 -0.06
10,00,000 115.06 203.46 -0.06
10,00,000 115.06 210.02 -0.06
10,00,000 115.06 82.53 -0.06

Shareholding Pattern

       
Promotors46.53%
Mutual Funds/UTI2.52%
FI/Banks2.79%
Insurance2.79%
FII33.24%
Government0.00%
Others4.08%

Peer Group

Company Intraday Graph
 Piramal Enterprises Ltd.
2,756.05(-0.34)
3356
 GlaxoSmithKline Pharmaceuticals Ltd.
2,443.20(-0.01)
3317
 Dr. Reddy`s Laboratories Ltd.
2,384.75(0.10)
3294
 Alkem Laboratories Ltd.
1,826.05(0.01)
17141

Exchange Information

NSE Index
Sensex
CNX 100
BSENAT
CNX 200
BSE200
CNX Bank
BSE500
CNX500
BSE Midcap
CNX Midcap
BSE Smallcap
Note: The scrip is a constituent of those NSE and BSE indices that have against them.

Company Indices

 1M (%)3M (%)6M (%)
Glenmark Pharmaceuticals Ltd.-0.70-85.40-286.00
NIFTY(S&P CNX)-6.55319.401,043.05
BSE SENSEX-33.80678.973,070.86
BSE 500-12.92572.761,510.79

Corporate Details

Key Personal
B E Saldanha
Non Executive Director
Bernard Munos
Non Executive Director
Brian W Tempest
Non Executive Director
Key Address
Registered Office
B/2 Mahalaxmi Chambers 22 Bhulabhai Desai Road,Mumbai,Maharashtra

Tel:022-40189999 40189879, Fax:022-40189986

csr@glenmarkpharma.com
http://www.glenmarkpharma.com
Registrar Office
Karvy Computershare Private Ltd.
Add. :Karvy Selenium Tower B Plot No. 31-32 Gachibowli Financial District Nanakramguda